These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27609977)

  • 1. Nephrolithiasis among male patients with newly diagnosed gout.
    Wan KS; Liu CK; Ko MC; Lee WK; Huang CS
    Hong Kong Med J; 2016 Dec; 22(6):534-7. PubMed ID: 27609977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography.
    Shimizu T; Hori H; Umeyama M; Shimizu K
    Int J Rheum Dis; 2019 Apr; 22(4):567-573. PubMed ID: 30485677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical profile of idiopathic uric acid nephrolithiasis.
    Pak CY; Sakhaee K; Peterson RD; Poindexter JR; Frawley WH
    Kidney Int; 2001 Aug; 60(2):757-61. PubMed ID: 11473659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gout attacks in chronic alcoholics occur at lower serum urate levels than in nonalcoholics.
    Vandenberg MK; Moxley G; Breitbach SA; Roberts WN
    J Rheumatol; 1994 Apr; 21(4):700-4. PubMed ID: 8035396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body lead stores and urate excretion in men with chronic renal disease.
    Lin JL; Huang PT
    J Rheumatol; 1994 Apr; 21(4):705-9. PubMed ID: 8035397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic values of urinary citrate for kidney stones in patients with primary gout].
    Wang Y; Zhang HM; Deng XR; Liu WW; Chen L; Zhao N; Zhang XH; Song ZB; Geng Y; Ji LL; Wang Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1134-1140. PubMed ID: 36533345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.
    Li ZX; Jiao GL; Zhou SM; Cheng ZY; Bashir S; Zhou Y
    BMC Nephrol; 2019 Jul; 20(1):273. PubMed ID: 31324154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Ramadan fast on patients with gout.
    Habib G; Badarny S; Khreish M; Khazin F; Shehadeh V; Hakim G; Artul S
    J Clin Rheumatol; 2014 Oct; 20(7):353-6. PubMed ID: 25275760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography.
    Shimizu T; Kitada H; Umeyama M; Hori H; Takasaki N
    J Urol; 2013 May; 189(5):1747-52. PubMed ID: 23159585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
    Hoff LS; Goldenstein-Schainberg C; Fuller R
    Adv Rheumatol; 2019 Dec; 60(1):2. PubMed ID: 31892344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.
    Shoji A; Yamanaka H; Kamatani N
    Arthritis Rheum; 2004 Jun; 51(3):321-5. PubMed ID: 15188314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of uric acid in calcium oxalate nephrolithiasis].
    Hartung R
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):387-90. PubMed ID: 804601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia and gout in thyroid endocrine disorders.
    Giordano N; Santacroce C; Mattii G; Geraci S; Amendola A; Gennari C
    Clin Exp Rheumatol; 2001; 19(6):661-5. PubMed ID: 11791637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of serum uric acid in cases of hyperuricaemia and gout.
    Pokharel K; Yadav BK; Jha B; Parajuli K; Pokharel RK
    JNMA J Nepal Med Assoc; 2011; 51(181):15-20. PubMed ID: 22335090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H
    Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.